SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ACTINIUM PHARMACEUTICALS INC
(NQPK:ATNM Last Sale: .18 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (ATNM : $.18)
$69,452 million Market Cap at Market Close, July 1, 2022
Drugs SubIndustry up .00% / Health Industry up .00% Today
New York, NY Research Report Earnings Snapshot - Last
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


Specialized in the development of cancer drugs. The Company’s product candidates are based on its patented technology co-developed with Memorial Sloan Kettering Cancer Center (MSKCC) for combining the cancer targeting precision of monoclonal antibodies (mAb) for targeting specific types of cells with the power of alpha emitting radioisotopes, the most potent cancer killing agents in existence.
Historical Charts    Technical Analysis
No Historical Data available for ATNM

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ATNM $.18 $.18 0 .0 $.18 $.19 5,403,598 $.18 $.19 385,843,700
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $69,451,866

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex